Moderators:

Vanessa Concepción Martín. Hospital Universitario Nuestra Señora de la Candelaria. Santa Cruz de Tenerife, Spain
Israel Manzanedo. Hospital Universitario de Fuenlabrada. Fuenlabrada. Madrid, Spain

  • Beyond PCI score: how small bowel involvement shapes survival in malignant peritoneal mesothelioma
    Alessandra Brescacin. Istituto Nazionale Tumori. Milan, Italy
  • Immunonutrition affects the preoperative proinflammatory status of patients with peritoneal carcinomatosis
    Araceli Mateo Díaz. Hospital Universitario Elche. Elche, Alicante
  • Non-inferiority of simplified surgery for acellular mucin serosal deposition in pseudomyxoma peritonei: a multicenter prospective randomized controlled trial
    Haipeng Zhou. Aerospace Center Hospital. Beijing, China
  • High-dose cisplatinum/doxorubicin/oxaliplatinum PIPAC for gastric colon appendix mesothelioma ovarian pc origin: a multicentric study of PSM-SICO (Italian Society of Surgical Oncology) – oncoteam purpose
    Marco Vaira. AOU Policlinico Di Modena. Modena. Italy
  • Bidirectional treatment of peritoneal metastasis with pressurized intraperitoneal aerosol chemotherapy (PIPAC) and systemic chemotherapy: a systematic review
    Manuela Robella. Candiolo Cancer Institute, FPO – IRCCS. Candiolo, Italy
  • Radiomics-clinical fusion model enhances detection of mesenteric contraction in pseudomyxoma peritonei
    Dong Bai. Aerospace Center Hospital. Beijing, China
  • Associations between preoperative cardiopulmonary exercise testing variables and postoperative outcomes in patients with peritoneal malignancy undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
    Tani Phillips. Sydney School of Health Sciences, The University of Sydney. Camperdown, Australia
  • A radiomics-based prediction of overall survival in colorectal cancer patients with peritoneal metastases
    QingFeng Lin. Sun Yat-Sen University. Canton, China
  • Insights into evolving practice outcomes and challenges: seven years after the establishment of a state-wide highly specialized peritoneal malignancy service
    Sascha Karunaratne. Royal Prince Alfred Hospital. Camperdown, Australia
October 29 @ 15:00
15:00 — 16:30 (1h 30′)